First Citizens Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-362	Closed	-$258K	–	534
2024 Q4	$258K	Buy	362 +85	+31%	+$71.3K	﹤0.01%	413
2024 Q3	$291K	Sell	277 -12	-4%	-$13.4K	0.01%	377
2024 Q2	$304K	Sell	289 -6	-2%	-$5.82K	0.01%	369
2024 Q1	$284K	Buy	+295	New	+$281K	0.01%	381
2023 Q1	–	Sell	-333	Closed	-$240K	–	338
2022 Q4	$240K	Buy	+333	New	+$246K	0.01%	290
2020 Q4	–	Sell	-2,273	Closed	-$1.27M	–	403
2020 Q3	$1.27M	Buy	2,273 +42	+2%	+$25.5K	0.09%	167
2020 Q2	$1.39M	Buy	+2,231	New	+$1.27M	0.12%	155
2016 Q1	–	Sell	-4,455	Closed	-$2.42M	–	448
2015 Q4	$2.42M	Sell	4,455 -5	-0.1%	-$2.71K	0.18%	110
2015 Q3	$2.08M	Sell	4,460 -150	-3%	-$80.6K	0.15%	123
2015 Q2	$2.35M	Sell	4,610 -150	-3%	-$73.2K	0.16%	122
2015 Q1	$2.15M	Sell	4,760 -150	-3%	-$63.6K	0.15%	125
2014 Q4	$2.01M	Sell	4,910 -198	-4%	-$77.9K	0.15%	117
2014 Q3	$1.84M	Buy	5,108 +1,948	+62%	+$653K	0.15%	115
2014 Q2	$893K	Buy	3,160 +190	+6%	+$56.3K	0.08%	167
2014 Q1	$892K	Sell	2,970 -3,464	-54%	-$1.07M	0.08%	162
2013 Q4	$1.77M	Sell	6,434 -5,771	-47%	-$1.66M	0.16%	116
2013 Q3	$3.82M	Buy	12,205 +5,089	+72%	+$1.34M	0.15%	160
2013 Q2	$1.6M	Buy	+7,116	New	+$1.66M	0.07%	271